Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
HaEmek Medical Center, Israel |
---|---|
Information provided by: | HaEmek Medical Center, Israel |
ClinicalTrials.gov Identifier: | NCT00560625 |
Inhaled corticosteroids are largely used in patients with asthma or chronic obstructive lung diseases. The purpose of this study is to determine if the use of inhaled corticosteroids is associated with suppression of endogenous cortisol production, as seen in patients treated with pharmacologic doses of oral or parenteral steroids.
Condition |
---|
Adrenal Insufficency |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Low Dose(1mcg) ACTH Stimulation Test for Assessment of the Hypothalamus-Pituitary-Adrenal Axis in Patients Treated With Inhaled Busedonide or Fluticasone. |
Estimated Enrollment: | 50 |
Study Start Date: | May 2007 |
Estimated Study Completion Date: | December 2008 |
The normalcy of the hypothalmic-pituitary-adrenal (HPA) axis of enrolled subjects will be assessed by low dose (1mcg) corticotropin (ACTH)stimulation test. Serum cortisol levels will be measured before , 30 minutes and 60 minutes after 1 mcg ACTH intravenous injection.
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
hospital-based respiratory diseases clinic
Inclusion Criteria:
Exclusion Criteria:
Contact: Avraham Ishay, MD | 97246495556 | ishay_av@clalit.org.il |
Contact: Rafael Luboshitzky, MD | 9726495553 | luboshitzky_r@clalit.org.il |
Israel | |
Endocrine Institute, Haemek medical Center | Recruiting |
Afula, Israel, 18101 | |
Principal Investigator: Avraham Ishay, MD |
Principal Investigator: | Avraham Ishay, MD | Endocrine Institute , Haemek Medical Center, Afula. 18101 Israel |
Study ID Numbers: | 0030-07EMC |
Study First Received: | November 18, 2007 |
Last Updated: | November 18, 2007 |
ClinicalTrials.gov Identifier: | NCT00560625 |
Health Authority: | Israel: Ethics Commission |
Fluticasone Epinephrine |
Anti-Inflammatory Agents Respiratory System Agents Autonomic Agents Therapeutic Uses Physiological Effects of Drugs Anti-Asthmatic Agents |
Anti-Allergic Agents Peripheral Nervous System Agents Dermatologic Agents Bronchodilator Agents Pharmacologic Actions |